Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
BMC Complement Med Ther ; 24(1): 231, 2024 Jun 12.
Artículo en Inglés | MEDLINE | ID: mdl-38867220

RESUMEN

BACKGROUND AND AIM: Traditional Chinese medicine (TCM) is widely used by patients with amyotrophic lateral sclerosis (ALS). However, their reasons and experience in using TCM have received insufficient attention. Therefore, we conducted a mixed method study to gain insights into this issue. MATERIALS AND METHODS: This study was conducted on the basis of the China Amyotrophic Lateral Sclerosis Registry of Patients with Traditional Chinese Medicine (CARE-TCM). Data were collected from Dongzhimen Hospital through a mixed method approach, including a questionnaire and a semi-structured interview. Patients with ALS who were using TCM when they were initially registered with CARE-TCM and who had been followed-up for over six months were recruited. The questionnaires' outcomes were statistically outlined, and the interview transcripts were thematically analysed to identify themes and sub-themes. RESULTS: Fifty-two and sixteen patients were included in the questionnaire and semi-structured interview groups, respectively. Patients used TCM with the hope of regulating their body holistically to improve nonmotor symptoms and quality of life (QOL). Those who recognised TCM as ineffective tended to discontinue it after a three-month trial period. Although quality was a major concern, herbal medicine (HM) was the most frequently used modality among all participants (n = 52), with the majority (n = 44, 84.6%) continuing to use it. Patients emphasised in-person consultations as a crucial part of TCM treatment. However, the disability caused by disease often made this interaction unattainable. CONCLUSION: Nonmotor symptoms and QOL hold substantial importance for patients with ALS using TCM. HM is a more suitable modality than other TCM treatment modalities, but patients are facing challenges in seeking HM treatment. It is necessary to promote the implementation of hierarchical diagnosis and treatment, thus making TCM more accessible. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT04885374 (registered on May 13, 2021).


Asunto(s)
Esclerosis Amiotrófica Lateral , Medicina Tradicional China , Humanos , Esclerosis Amiotrófica Lateral/tratamiento farmacológico , Medicina Tradicional China/métodos , Femenino , Masculino , Persona de Mediana Edad , Encuestas y Cuestionarios , Anciano , China , Adulto , Calidad de Vida , Investigación Cualitativa
2.
Front Pharmacol ; 13: 946548, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36120351

RESUMEN

Background: The effect of herbal medicine (HM) on amyotrophic lateral sclerosis (ALS) is controversial. Clinical trials investigating HMs continue; however, the use of HM is still questioned. We aimed to systematically review the literature pertaining to the effects and safety of HM in ALS. Methods: Randomised controlled trials (RCTs) that investigated the efficacy of HMs in ALS patients compared to any types of controls were identified. Nine databases and six registers were searched from their inception dates to 25 March 2022. Per the PRISMA guidelines, trials were identified and extracted. The risk of bias was evaluated using the Cochrane's tool. Certainty of evidence was assessed as per the GRADE criteria. Forest plots were constructed to assess the effect size and corresponding 95% CIs using fixed-effect models, and random-effect models were employed when required. The primary outcome was the activity limitation measured by validated tools, such as the revised ALS Functional Rating Scale. Results: Twenty studies (N = 1,218) were eligible. Of these, only five studies were double-blinded, and two were placebo-controlled. Fourteen HMs (fifty-one single botanicals) were involved; Astragalus mongholicus Bunge, Atractylodes macrocephala Koidz., and Glycyrrhiza glabra L. were commonly used in nine, eight, and six trials, respectively. For delaying activity limitation, Jiweiling injection (MD, 2.84; 95% CI, 1.21 to 4.46; p = 0.0006) and Shenmai injection (SMD, 1.07; 0.69 to 1.45; p < 0.00001) were significantly more efficacious than Riluzole, but the evidence was low quality. For ameliorating motor neuron loss, Jiweiling injection [right abductor pollicis brevis (APB): MD, 32.42; 7.91 to 56.93; p = 0.01 and left APB: MD, 34.44; 12.85 to 56.03; p = 0.002] was favoured, but the evidence was very low quality. Nine studies reported one hundred and twenty-three adverse events, twenty-six of which occurred in the treatment groups and ninety-seven in the control groups. Conclusion: Very low to low quality of evidence suggests that HMs seem to produce superior treatment responses for ALS without increased risk of adverse events. Additional studies with homogeneous participants, reduced methodological issues, and more efficient outcome measures are required to provide confirmatory evidence. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42021277443.

3.
Sci Total Environ ; 818: 151677, 2022 Apr 20.
Artículo en Inglés | MEDLINE | ID: mdl-34793795

RESUMEN

The Gravity Recovery and Climate Experiment (GRACE) satellites provide a powerful tool for monitoring sediment mass change. However, signal leakage from nearby groundwater storage depletion in the North China Plain limits the potential capacity of GRACE to estimate sediment input from the Yellow River flows into the Bohai Sea. In the present work, we developed an improved approach based on forward modeling to reduce signal leakage from GRACE data and combined it with satellite altimetry to recover sediment load changes from 2003 to 2013 to the Bohai Sea. The total sediment input averaged 1.7 ± 0.8 Gt/yr, which agrees well with the estimate based on in-situ sediment data measured from the sediment cores (1.1 Gt/yr). Our method is also capable to describe sediment seasonal variations, with higher inputs in winter and spring, which confirm the output simulated by the sediment transportation model. We make presently tentative connections of seasonal variations to sediment resuspension driven by climatic monsoons contributed rough seas: although sediment load in rivers peaks in summer, low water discharge of the Yellow River leads to most of the sediment being deposited in a narrow area near the river mouth and not transported into the Bohai Sea; in winter and spring, huge waves provide favorable conditions for resuspension resulting in large amounts of sediment near the estuary being transported to the ocean along with northward waves. Moreover, our results indicate coastal erosion is also a nonnegligible resource of the sediment in the Bohai Sea. Comparing to the traditional approach, our study provides a new technological way to derive sediment in the Bohai Sea, which is capable of providing continuous measurements with improved timeliness at a lower cost.


Asunto(s)
Monitoreo del Ambiente , Contaminantes Químicos del Agua , China , Monitoreo del Ambiente/métodos , Estuarios , Sedimentos Geológicos , Océanos y Mares , Ríos , Contaminantes Químicos del Agua/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...